We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC ...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, ...

Whitehawk Therapeutics Inc is listed on the CBOE trading with ticker code WHWK.US. It has a market capitalisation of $82.91m, with approximately 47.11m shares in issue.

* EPS estimates are GAAP unless otherwise noted.

MORRISTOWN, N.J., May 28, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to ...

Retail Sales Stall as PPI and Fed Surveys Signal Uneven Consumer DemandThu, 15 May 2025 13:33:06 GMT Walmart Beats Q1, Gains 2.5% Premarket on E-Commerce Strength and Solid U.S. SalesThu, 15 May ...

MORRISTOWN, N.J., May 21, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

FNCH Finch Therapeutics Group, Inc.